Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. ACN
5. IBM
6. META
7. SPY
8. NVDA
9. PRIM
10. PFE

Go back to Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update

Protalix BioTherapeutics (PLX) Misses Q3 EPS by 9c; Reports Cash and Cash Equivalents of $48.7M

November 15, 2021 6:51 AM EST

Protalix BioTherapeutics (NYSE: PLX) reported Q3 EPS of ($0.09), $0.09 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $12.05 million versus the consensus estimate of $6.9 million.

For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.

... More